Brain tumor treatment: Chemotherapy and other new developments

Seminars in Oncology Nursing

Volumn 20, Issue 4, 2004, Pages 260-272

  Graham, Carrie Anne ^a,b   Cloughesy, Timothy F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b 710 Westwood Plaza   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 AMINO 1,3 DIHYDRO 1 OXO 2H ISOINDOL 2 YL)GLUTARIMIDE; ALKYLATING AGENT; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CAMPTOTHECIN DERIVATIVE; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSTATIC AGENT; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; GEFITINIB; IRINOTECAN; LOMUSTINE; MANNITOL; METHOTREXATE; NITROSOUREA; PROCARBAZINE; PROTEIN INHIBITOR; RETINOIC ACID; RETINOL DERIVATIVE; TAMOXIFEN; TEMOZOLOMIDE; THALIDOMIDE; UNINDEXED DRUG; VINCRISTINE;

ALOPECIA; ANEMIA; BIRTH DEFECT; BONE MARROW SUPPRESSION; BRAIN LYMPHOMA; BRAIN METASTASIS; BRAIN TUMOR; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONSTIPATION; DEEP VEIN THROMBOSIS; FATIGUE; GLIOBLASTOMA; HUMAN; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MEDULLOBLASTOMA; MENOPAUSAL SYNDROME; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; RASH; RETINOPATHY; REVIEW; SKIN DISEASE; SOMNOLENCE; TERATOGENICITY; THROMBOCYTOPENIA; VOMITING;

EID: 8444240128     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-2081(04)00090-7     Document Type: Review

References (62)

1. K. Thapar, J.T. Rutka, E.R. Laws Brain edema, increased intracranial pressure, vascular effects, and other epiphenomena of human brain tumors A.H. Kaye E.R. Laws Brain tumors 1995 Churchill Livingstone New York, NY 163 189
2. Central Brain Tumor Registry of the United States Statistical Report Primary Brain Tumors in the United States, 1992-1997 2000 Central Brain Tumor Registry of the United States Chicago, IL
3. I.F. Pollack, L.D. Lunsford, J.C. Flickinger Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma Cancer 63 1989 939 947
4. L.M. DeAngelis, J. Yahalom Primary central nervous system lymphoma V.T. DeVita S. Hellman S.A. Rosenberg Cancer principles and practice of oncology 2001 Lippincott Williams & Wilkins Philadelphia, PA 2330 2337
5. D.F. Nelson, K.L. Martz, H. Bonner Non-Hodgkin"s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315 Int J Radiat Oncol Biol Phys 23 1992 9 17
6. S. Camilleri-Broet, A. Martin, A. Moureau Primary central nervous system lymphoma in 72 immunocompetent patients, pathologic findings and clinical correlations Am J Clin Pathol 110 1998 607 612
7. L.M. DeAngelis, W. Seiferheld, S.C. Schold Combination chemotherapy and radiotherapy for primary central nervous system lymphoma Radiation Therapy Oncology Group Study 93-10 J Clin Oncol 20 2002 4643 4648
8. T. Batchelor, K. Carson, A. O'Neill Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy a report of NABTT 96-07 J Clin Oncol 21 2003 1044 1049
9. D.F. Kraemer, D. Fortin, E.A. Neuwelt Chemotherapeutic dose intensification for treatment of malignant brain tumors recent developments and future directions Curr Neurol Neurosci Rep 2 2002 216 224
10. C. Soussain, F. Suzan, K. Hoang-Xuan Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma J Clin Oncol 19 2001 742 749
11. L.E. Abrey, C.H. Moskowitz, W.P. Mason Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem cell rescue in patients with primary CNS lymphoma an attempt to treat analysis J Clin Oncol 21 2003 1451 1456
12. A.A. Brandes, V. Palmisano, S. Monfardini Medulloblastoma in adults clinical characteristics and treatment Cancer Treat Rev 25 1999 3 12
13. C.A. Mazzola, I.F. Pollack Medulloblastoma Curr Treat Options Neurol 5 2003 189 198
14. E. Galanis, J. Buckner, P. Schomberg Effective chemotherapy for advanced CNS embryonal tumors in adults J Clin Oncol 15 1997 2939 2944
15. J.B. Posner, N.L. Chernik Intracranial metastases from systemic cancer Adv Neurol 19 1978 579 592
16. A.B. Lassman, L.M. DeAngelis Brain metastases Neurol Clin 21 2003 1 23
17. L.E. Abrey, J.D. Olson, J.J. Raizer A phase II trial of temozolomide for patients with recurrent or progressive brain metastases J Neurooncol 53 2001 259 265
18. G. Biasco, M.A. Pantaleo, S. Casadai Treatment of brain metastases of malignant melanoma with temozolomide N Engl J Med 345 2001 621 622
19. W.J. Hwu, S.E. Krown, J.H. Menell A phase II trial of temozolomide plus thalidomide for the treatment of metastatic melanoma J Clin Oncol 21 2003 3351 3356
20. A. Katz, P. Zalewski Quality-of-life benefits and evidence of antitumor activity for patients with brain metastases treated with gefitinib Br J Cancer 89 suppl 2 2003 S15 S18
21. F. Cappuzzo, A. Ardizzoni, H. Soto-Parra Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC) Lung Cancer 41 2003 227 231
22. Medical Research Council Brain Tumor Working Party Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma a medical research council trial J Clin Oncol 19 2001 509 518
23. H.A. Fine, K.B. Dear, J.S. Loeffler Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 17 1993 2585 2597
24. L.A. Stewart Chemotherapy in adult high-grade glioma a systematic review and meta-analysis of individual patient data from 12 randomized trials Lancet 359 2002 1011 1018
25. R. Stupp, P.Y. Dietrich, S. Ostermann Kraljevic Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 2002 1375 1382
26. R. Stupp, W.P. Mason, M.J. Van Den Bent Concomitant and adjuvant temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme. Conclusive results of a randomized phase III trial by the EORTC Brain & RT groups and NCIC Clinical Trials Group Proc Am Soc Clin Oncol 22 2004 14S
27. V.A. Levin, P. Silver, J. Hannigan Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas NCOG 6G61 final report Int J Radiat Oncol Biol Phys 18 1990 321 324
28. M.D. Prados, C. Scott, W.J. Curran Jr. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma a retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy J Clin Oncol 17 1999 3389 3395
29. H.B. Newton, L. Junck, J. Bromberg Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure Neurology 40 1990 1743 1746
30. N.M. Bleehen, L.S. Freedman, S.P. Stenning A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma. Report to the Medical Research Council by the Brain Tumor Working Party Int J Radiat Oncol Biol Phys 16 1989 1077 1081
31. W.K. Yung, M.D. Prados, R. Yaya-Tur Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group J Clin Oncol 17 1999 2762 2771
32. W.K. Yung, R.E. Albright, J. Olson A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83 2000 588 593
33. D. Osaba, M. Brada, W.K.A. Yung Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme J Clin Oncol 18 2000 1481 1491
34. M.D. Prados, R.E. Warnick, E.E. Mack Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial Am J Clin Oncol 19 1996 609 612
35. W.K. Yung, L. Mechtler, M.J. Gleason Intravenous carboplatin for recurrent malignant glioma a phase II study J Clin Oncol 9 1991 860 864
36. R.E. Warnick, M.D. Prados, E.E. Mack A phase II study of intravenous carboplatin for the treatment of recurrent gliomas J Neurooncol 19 1994 69 74
37. T.F. Cloughesy, E. Filka, J. Kuhn Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every 3-week regimen Cancer 97 suppl 9 2003 2381 2386
38. H.S. Friedman, W.P. Petros, A.H. Friedman Irinotecan therapy in adults with recurrent or progressive malignant glioma J Clin Oncol 17 1999 1516 1525
39. M.R. Gilbert, P. Wen, F. Lieberman Phase I/II study of combination temozolomide and irinotecan for recurrent malignant gliomas A North American Brain Tumor Consortium (NABTC) Study [abstract] Proc Am Soc Clin Oncol 22 2003 103
40. I.A. Parney, S.M. Chang Current chemotherapy for glioblastoma Cancer J 9 2003 149 156
41. D. Fulton, R. Urtasun, P. Forsyth Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma J Neurooncol 27 1996 149 155
42. M.C. Chamberlain, P.A. Kormanik Salvage chemotherapy with tamoxifen for recurrent anaplastic astrocytomas Arch Neurol 56 1999 703 708
43. W.T. Couldwell, D.R. Hinton, A.A. Surnock Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen Clin Cancer Res 2 1996 19 22
44. W.K.A. Yung, A.P. Kyritsis, M.J. Gleason Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid Clin Cancer Res 2 1996 1931 1935
45. K.A. Jaeckle, K.R. Hess, W.K.A. Yung Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma A North American Brain Tumor Consortium Study J Clin Oncol 21 2003 2305 2311
46. H.A. Fine, W.D. Figg, K. Jaeckle Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas J Clin Oncol 18 2000 708 715
47. H.A. Fine, L. Kim, C. Royce A phase I trial of CC-5013, a potent thalidomide analog, in patients with recurrent high-grade gliomas and other refractory CNS malignancies [abstract] Proc Am Soc Clin Oncol 22 2003 105
48. H.A. Fine, P.Y. Wen, E.A. Maher Phase II of thalidomide and carmustine for brain tumor patients with recurrent high-grade gliomas J Clin Oncol 21 2003 2299 2304
49. G. Cairncross, D. MacDonald, S. Ludwin Chemotherapy for anaplastic oligodendrogliomas J Clin Oncol 12 1994 2013 2021
50. V.K. Puduvalli, M. Hashmi, L.D. McAllister Anaplastic oligodendrogliomas prognostic factors for tumor recurrence and survival Oncology 65 2003 259 266
51. M.J. Van den Bent, M.J.B. Taphoorn, A.A. Brandes Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971 J Clin Oncol 21 2003 2525 2528
52. J.G. Cairncross, K. Ueki, M.C. Zlatescu Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 19 1998 1473 1479
53. J.H. Rees Low-grade gliomas in adults Curr Opin Neurol 15 2002 657 661
54. H.J. Eyre, J.R. Eltringham, J. Crowley A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas Southwest Oncology Group study J Neurosurg 78 1993 909 914
55. J.C. Buckner, D. Gesme Jr, J.R. O"Fallon Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma efficacy and associations with chromosomal abnormalities J Clin Oncol 21 2003 251 255
56. C.L. Sawyers, A. Hochhaus, E. Feldman Myeloid blast crisis: results of a phase II study. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study Blood 99 2002 3530 3539
57. M. Fukuoka, S. Yano, G. Giaccone Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol 21 2003 2227 2229
58. P.S. Mischel, T.F. Cloughesy Targeted molecular therapy of GBM Brain Pathol 13 2003 52 61
59. I.W. Tremonts-Lukats, M.R. Gilbert Advances in molecular therapies in patients with brain tumors Cancer Control 10 2003 125 137
60. T.S. Armstrong, M.R. Gilbert Chemotherapy of astrocytomas an overview Semin Oncol Nurs 14 1998 18 25
61. D. Schiff Pneumocystis pneumonia in brain tumor patients risk factors and clinical features J Neurooncol 27 1996 235 240
62. T.S. Armstrong, M.R. Gilbert Glial tumors - new approaches in chemotherapy J Neurosci Nurs 34 2002 326 330